Use of First- and Second-Generation Cyclooxygenase-2–Selective Nonsteroidal Antiinflammatory Drugs and Risk of Acute Myocardial Infarction
Frank Andersohn(Charité - Universitätsmedizin Berlin), Edeltraut Garbe(Charité - Universitätsmedizin Berlin), Samy Suissa(Jewish General Hospital)
Cited by 176
Related Papers
Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management.
|PubMed|1995|1.9k
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
|New England Journal of Medicine|2007|714
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
|Annals of Internal Medicine|2007|476